Related Experiment Video
Updated: Jun 23, 2026

Packaging HIV- or FIV-based Lentivector Expression Constructs & Transduction of VSV-G Pseudotyped Viral Particles
Published on: April 8, 2012
Tailoring the Methods of Conjugation and Characterization for a Replication-Competent, Live, Viral Vector
Elise Ishida1, Richard Dambra1, Sally Ye1
1Drug Metabolism and Pharmacokinetics (DMPK), Boehringer Ingelheim Pharmaceuticals, Inc, 900 Ridgebury Rd, Ridgefield, Connecticut 06877, United States.
Abstract:
Optimized functionalization of virus particles can expand the toolbox available for the development of viral vector-based therapies. However, labeling of a large, complex, and biologically active particle introduces distinct technological challenges for subsequent purification and characterization steps. Moreover, the process of labeling and purification, and even the label itself, may have an unwanted impact on the particle's biological activity. Herein, we present a comprehensive series of steps for conjugation, purification, and characterization that are adapted from traditional biologics (e.g., monoclonal antibodies) and apply them to the replication-competent rhabdovirus VSV-GP-GFP. By confirming purity and quantifying the average degree of labeling (DoL), we tailored the label/particle ratio to generate tool viruses suitable for downstream applications in nonclinical and clinical development. These methods will enhance the development of viral vector therapies and hasten their delivery to patients in need.
Related Concept Videos
What are Viruses?
Viral Structure
Lytic Cycle of Bacteriophages
Retrovirus Life Cycles
Retroviruses
Size and Structure of Viral Genomes

